Search results

• 

  [Nal3,Lys5(Boc)]octreotide acetate

  
  9903

  Precursor for N-terminal substituted [Nal3]octreotide analogs

  [Nal3,Lys5(Boc)]octreotide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-N⁶-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide

• 

  (2S,4R)-4-Fluoroglutamine precursor

  
  3198

  Precursor for (2S,4R)-4-[¹⁸F]Fluoroglutamine

  L-​Glutamine, N²-​[(1,​1-​dimethylethoxy)​carbonyl]​-​4-​[[(4-​methylphenyl)​sulfonyl]​oxy]​-N-​[(2,​4,​6-​trimethoxyphenyl)​methyl]​-​, 1,​1-​dimethylethyl ester, (4S)​-; tert-butyl (2S,4S)-2-((tert-butoxycarbonyl)amino)-5-oxo-4-(tosyloxy)-5-((2,4,6-trimethoxybenzyl)amino)pentanoate; (2S,4R)-4-[¹⁸F]Fluoroglutamine precursor

• 

  NODAGA-RGD dimer acetate

  
  9804

  Precursor for radiolabelled NODAGA-RGD dimer

  Cyclo(L-arginylglycyl-L-α-aspartyl-D-tyrosyl-L-lysyl), N⁶-([[4,7-bis(carboxymethyl)octahydro-1H-1,4,7-triazonin-1-yl]acetyl])-L-glutamoyl]bis-

• 

  DOTA-TOC acetate

  
  9701

  Precursor for radiolabelled DOTA-TOC

  DOTA-[Tyr³]-octreotide; CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-,

• 

  Ga-NODAGA-RGD

  
  9807

  Reference standard for ⁶⁸Ga-NODAGA-RGD

  Cyclo[L-arginylglycyl-L-α-aspartyl-D-tyrosyl-N⁶-([[4,7-bis(carboxymethyl)octahydro-1H-1,4,7-triazonin-1-yl]-4-carboxy-butyryl])-L-lysyl], complex with Ga3+

• 

  CMTMA

  
  4386

  Precursor for meta-[¹⁸F]Fluorobenzylguanidine

  3-Nitrilo phenyltrimethylammonium trifluoromethanesulfonate;(3-Cyano-phenyl)-trimethyl-ammonium, trifluoro-methanesulfonate; Benzenaminium, 3-cyano-N,N,N-trimethyl-, salt with trifluoromethanesulfonic acid (1:1); meta-[¹⁸F]Fluorobenzylguanidine precursor

• 

  Lu-DOTA-TOC

  
  9705

  Reference standard for [¹⁷⁷Lu]Lu-DOTA-TOC

  Lu-Edotreotide; Lu-SMT487; Lu-DOTA-[Tyr3]octreotide; Lutetium-175Lu, [N-[2-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic(2→7)-disulfidato(3-)]-; Lutetium-175Lu, [N-[[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic(2→7)-disulfidato(3-)]-

• 

  2',3'-Didehydro-3'-deoxythymidine

  
  2954

  Reference standard for byproduct of [¹⁸F]FLT synthesis (3'-deoxy-3'-[¹⁸F]fluorothymidine)

  3'-Deoxy-2',3'-didehydrothymidine; 3'-deoxythymidin-2'-ene; 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-[2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl]thymine; BMY 27857; D 4T; D4T (nucleoside); NSC 163661; Sanilvudine; Stavir; Stavudine; Zerit

• 

  2'-Fluoro-thymidine

  
  1260

  Reference standard for 2'-[¹⁸F]Fluoro-thymidine

  2'-Deoxy-2'-fluorothymidine; 1-(2'-Deoxy-2'-fluoro-β-D-ribofuranosyl)-5-methyluracil; 2,4(1H,3H)-Pyrimidinenone, 1(2-deoxy-2-fluoro-β-D-ribofuranosyl)-5-methyl; 2'-Deoxy-2'-fluoro-5-methyluridine; 5-Methyl-2'-fluoro-D-uridine; 5-Methyl-2'-fluorouracil; 2'-Fluoro-2'-deoxythymidine

• 

  Ethyl 4-nitrobenzoate

  
  4376

  Precursor for [¹⁸F]FB (4-[¹⁸F]fluorobenzoic acid)

  4-(Ethoxycarbonyl)nitrobenzene; 4-Ethoxycarbonyl-1-nitrobenzene; 4-Nitrobenzoic acid ethyl ester; [18F]FB precursor

• 

  Y-DOTA-TOC

  
  9704

  Reference Standard for [⁹⁰Y]Y-DOTA-TOC

  ^natY-Edotreotide; ^natY-SMT487; ^natY-DOTA-[Tyr3]octreotide; Yttrium, [N-[2-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN¹,κN⁴,κN⁷,κN¹⁰]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfidato(3-)]-

• 

  Ga-DOTA-TOC acetate

  
  9703

  Reference standard for [⁶⁸Ga]Ga-DOTA-TOC

  ^natGa-Edotreotide; ^natGa-SMT487; ^natGa-DOTA-[Tyr3]octreotide; Gallium, [N-[[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN¹,κN⁴,κN⁷,κN¹⁰]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide(2→7)-disulfidato(3-)]-

• 

  NODAGA-AMBA trifluoroacetate

  
  9814
  NODAGA-AMBA trifluoroacetate; L-Methioninamide, N-[4-carboxy,4-[4,7-bis(carboxymethyl)octahydro-1H-1,4,7-triazonin-1-yl]-butanoyl]glycyl-4-aminobenzoyl-L-glutaminyl-L-tryptophyl -L-alanyl-L-valylglycyl-L-histidyl-L-leucyl-, TFA salt

• 

  [Tyr3]Octreotide acetate

  
  9810

  Potent somatostatin analog

  [Tyr3]-SMS 201-995; CA index name: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)- 2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic(2→7) disulfide

• 

  Ga-DOTA-NOC

  
  9717

  Reference standard for [⁶⁸Ga]Ga-DOTA-NOC

  Ga-DOTANOC; CA index name: Gallate(1-), [N-[[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN¹,κN⁴,κN⁷,κN¹⁰]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threonine cyclic (2→7)-disulfidato(4-)]-

• 

  6-FDG precursor

  
  1109

  Precursor for 6-[¹⁸F]FDG (6-[¹⁸F]fluoro-6-deoxy-D-glucose)

  α-D-Glucofuranose, 1,2-O-(1-methylethylidene)-3,5-O-[(S)-phenylmethylene]-, 4-methylbenzenesulfonate

• 

  HYNIC-TOC trifluoroacetate

  
  9721

  Precursor for [⁹⁹^mTc]HYNIC-TOC

  HYNIC-[Tyr3] Octreotide; CA index name: L-Cysteinamide, N-[(6-hydrazinyl-3-pyridinyl)carbonyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl- N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide

• 

  [Tyr3,Lys5(Boc)]octreotide acetate

  
  9900

  Precursor for N-terminal substituted octreotide analogs

  [Lys(Boc)5]TOC; CA index name: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-N⁶-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide

• 

  Octreotide acetate
  

  
  9750
  Octreotide acetate; Sandostatin; Sandostatin LAR; SMS 201-995ac; CA index name: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, acetate (salt)
  

• 

  DOTA-TOC (GMP)

  
  9702

  Precursor for radiolabelled DOTA-TOC

  DOTA-TOC acetate; DOTA-[Tyr3]-octreotide; Edotreotide; CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic(2→7)-disulfide, supplied as acetate salt

• 

  FFNP precursor

  
  1926

  Precursor for [¹⁸F]FFNP ([¹⁸F]fluoro furanyl norprogesterone)

  16α,17α-[(R)-(1'-α-Furylmethylidene)dioxy]-21[(methyl)sulfonyl]oxy-19-norpregn-4-ene-3,20-dione; [¹⁸F]FFNP precursor

• 

  HMDP

  
  7161

  Ligand for labelling with ^99mTc

  Disodium (hydroxymethylene)diphosphonate; Disodium methane-1-hydroxy-1,1-diphosphonate; Methanehydroxydiphosphonic acid disodium salt; Oxidronate sodium; Oxidronic acid sodium salt; Sodium oxidronate

• 

  EKAP precursor

  
  2073

  Precursor for [¹¹C]EKAP

  [¹¹C]EKAP precursor

• 

  Iodo-Darolutamide

  
  1952

  Precursor for [¹¹C]Darolutamide

  [¹¹C]Darolutamide precursor

• 

  FLT Ultra Pure

  
  1219

  Reference standard for [¹⁸F]FLT (3'-deoxy-3'-[¹⁸F]fluorothymidine)

  1-(3'-Deoxy-3'-fluoro-β-D-pentofuranosyl)thymine; 3'-Deoxy-3'-fluorothymidine; 3'-Fluorodeoxythymidine; 3'-Fluorothymidine; Alovudine; CL 184824; 3'-Fluoro-3'-deoxythymidine

• previous
• 1
• ...
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• next